{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:31:49Z","timestamp":1783431109452,"version":"3.54.6"},"reference-count":35,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Omnipod DASH Insulin Management System is a tubeless insulin pump that overcomes the physical inconveniences of conventional tubed insulin pump therapy (IPT).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We compared treatment satisfaction with Omnipod DASH System to usual care (multiple daily injections [MDIs] or tubed IPT) in adults with type 1 diabetes using self-monitoring blood glucose (SMBG).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Adults with type 1 diabetes on MDI (n = 40) or IPT (n = 25) from 4 diabetes centers in Australia were randomly assigned in a 1:1 nonblinded manner to Omnipod DASH System (Omnipod group) or continue usual care (Usual Care group) for 12 weeks, followed by a further 12-week extension during which all participants used the device. The primary outcome was treatment satisfaction assessed by change in Diabetes Technology Questionnaire \u201ccurrent\u201d (\u0394DTQ-current) score at 12 weeks (study end). Secondary outcomes included \u0394DTQ-current following extension and other participant-reported outcomes (PROs) measuring quality of life, burden of disease treatment, and glycemic and device-related outcomes at 12 weeks (study end) and 24 weeks (end extension).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Treatment satisfaction improved more in the Omnipod group vs the Usual Care group (\u0394DTQ-current score of 16.4 [21.2] vs 0.0 [12.8]; P &amp;lt; .001) at study end. Significantly greater improvements in other PROs and glycated hemoglobin A1c were also observed. Improvements in DTQ-current and other PROs comparing study end and end extension were similar. While percentage in time in range change from baseline did not differ at study end (\u22122.0 [12.7] %), it was significantly greater at end extension (5.6 [10.9] %; P = .016).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The Omnipod DASH System resulted in greater treatment satisfaction at 12 weeks in adults with type 1 diabetes using SMBG that was sustained after 24 weeks of device use without compromising sleep quality and fear of hypoglycemia. Improvements in glycemia were also observed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae088","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T20:27:07Z","timestamp":1708374427000},"page":"1984-1995","source":"Crossref","is-referenced-by-count":5,"title":["Treatment Satisfaction With Omnipod DASH in Adults With Type 1 Diabetes: A Nonblinded 1:1 Randomized Controlled Trial"],"prefix":"10.1210","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7099-8983","authenticated-orcid":false,"given":"Yee Wen","family":"Kong","sequence":"first","affiliation":[{"name":"Diabetes Technology Research Group, The University of Melbourne , Melbourne, Victoria 3065 , Australia"},{"name":"Department of Endocrinology and Diabetes, St Vincent's Hospital Melbourne , Melbourne, Victoria 3065 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng Yi","family":"Yuan","sequence":"additional","affiliation":[{"name":"Diabetes Technology Research Group, The University of Melbourne , Melbourne, Victoria 3065 , Australia"},{"name":"Department of Endocrinology and Diabetes, St Vincent's Hospital Melbourne , Melbourne, Victoria 3065 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Kiburg","sequence":"additional","affiliation":[{"name":"Diabetes Technology Research Group, The University of Melbourne , Melbourne, Victoria 3065 , Australia"},{"name":"Department of Endocrinology and Diabetes, St Vincent's Hospital Melbourne , Melbourne, Victoria 3065 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Brown","sequence":"additional","affiliation":[{"name":"Diabetes Technology Research Group, The University of Melbourne , Melbourne, Victoria 3065 , Australia"},{"name":"Department of Endocrinology and Diabetes, St Vincent's Hospital Melbourne , Melbourne, Victoria 3065 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Trawley","sequence":"additional","affiliation":[{"name":"Diabetes Technology Research Group, The University of Melbourne , Melbourne, Victoria 3065 , Australia"},{"name":"Department of Psychology, Cairnmillar Institute , Camberwell, Victoria 3124 , Australia"},{"name":"Department of Medicine, The University of Melbourne , Melbourne, Victoria 3065 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andi","family":"Partovi","sequence":"additional","affiliation":[{"name":"Keylead Health , Melbourne, Victoria 3065 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerryn","family":"Roem","sequence":"additional","affiliation":[{"name":"Diabetes Technology Research Group, The University of Melbourne , Melbourne, Victoria 3065 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Pham","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Melbourne , Melbourne, Victoria 3065 , Australia"},{"name":"Department of Endocrinology, Austin Health , Heidelberg, Victoria 3084 , Australia"},{"name":"The Australian Centre for Accelerating Diabetes Innovations (ACADI), The University of Melbourne , Melbourne, Victoria 3010 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Harrison","sequence":"additional","affiliation":[{"name":"Geelong Endocrinology and Diabetes , Geelong, Victoria 3220 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spiros","family":"Fourlanos","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Melbourne , Melbourne, Victoria 3065 , Australia"},{"name":"The Australian Centre for Accelerating Diabetes Innovations (ACADI), The University of Melbourne , Melbourne, Victoria 3010 , Australia"},{"name":"Department of Diabetes and Endocrinology, The Royal Melbourne Hospital , Melbourne, Victoria 3052 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif I","family":"Ekinci","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Melbourne , Melbourne, Victoria 3065 , Australia"},{"name":"Department of Endocrinology, Austin Health , Heidelberg, Victoria 3084 , Australia"},{"name":"The Australian Centre for Accelerating Diabetes Innovations (ACADI), The University of Melbourne , Melbourne, Victoria 3010 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0870-4032","authenticated-orcid":false,"given":"David N","family":"O\u2019Neal","sequence":"additional","affiliation":[{"name":"Diabetes Technology Research Group, The University of Melbourne , Melbourne, Victoria 3065 , Australia"},{"name":"Department of Endocrinology and Diabetes, St Vincent's Hospital Melbourne , Melbourne, Victoria 3065 , Australia"},{"name":"Department of Medicine, The University of Melbourne , Melbourne, Victoria 3065 , Australia"},{"name":"The Australian Centre for Accelerating Diabetes Innovations (ACADI), The University of Melbourne , Melbourne, Victoria 3010 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,2,19]]},"reference":[{"issue":"6","key":"2024071216422907600_dgae088-B1","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00125-008-0974-3","article-title":"Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis","volume":"51","author":"Jeitler","year":"2008","journal-title":"Diabetologia"},{"issue":"14","key":"2024071216422907600_dgae088-B2","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jama.2017.13994","article-title":"Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes","volume":"318","author":"Karges","year":"2017","journal-title":"JAMA"},{"issue":"9","key":"2024071216422907600_dgae088-B3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00592-019-01326-5","article-title":"Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials","volume":"56","author":"Pala","year":"2019","journal-title":"Acta Diabetol"},{"issue":"1","key":"2024071216422907600_dgae088-B4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4158\/EP.11.1.55","article-title":"The Dawn phenomenon revisited: implications for diabetes therapy","volume":"11","author":"Carroll","year":"2005","journal-title":"Endocr Pract"},{"key":"2024071216422907600_dgae088-B5","doi-asserted-by":"crossref","first-page":"109000","DOI":"10.1016\/j.diabres.2021.109000","article-title":"Meal-time glycaemia in adults with type 1 diabetes using multiple daily injections vs insulin pump therapy following carbohydrate-counting education and bolus calculator provision","volume":"179","author":"Lu","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"2024071216422907600_dgae088-B6","first-page":"93","article-title":"Continuous subcutaneous insulin infusion versus multiple daily injections","volume":"13","author":"Karagianni","year":"2009","journal-title":"Hippokratia"},{"issue":"8","key":"2024071216422907600_dgae088-B7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1089\/dia.2023.0038","article-title":"Prevalence of and reasons for discontinuation of continuous subcutaneous insulin infusion in people with type 1 diabetes: a systematic review","volume":"25","author":"Dekker","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"2024071216422907600_dgae088-B8","doi-asserted-by":"crossref","first-page":"110830","DOI":"10.1016\/j.diabres.2023.110830","article-title":"\u201cEmpowering us\u201d: a community-led survey of real-world perspectives of adults with type 1 diabetes using insulin pumps and continuous glucose monitoring to manage their glucose levels","volume":"202","author":"Read","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2024071216422907600_dgae088-B9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/dia.2009.0080","article-title":"Attitudes towards insulin pump therapy among adolescents and young people","volume":"12","author":"Seereiner","year":"2010","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"2024071216422907600_dgae088-B10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2337\/ds18-0091","article-title":"A clinical overview of insulin pump therapy for the management of diabetes: past, present, and future of intensive therapy","volume":"32","author":"Berget","year":"2019","journal-title":"Diabetes Spectr"},{"issue":"10","key":"2024071216422907600_dgae088-B11","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/dia.2011.0047","article-title":"Comparison of a novel insulin bolus-patch with pen\/syringe injection to deliver mealtime insulin for efficacy, preference, and quality of life in adults with diabetes: a randomized, crossover, multicenter study","volume":"13","author":"Bohannon","year":"2011","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"2024071216422907600_dgae088-B12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/dia.2018.0298","article-title":"Implementation of basal-bolus therapy in type 2 diabetes: a randomized controlled trial comparing bolus insulin delivery using an insulin patch with an insulin pen","volume":"21","author":"Bergenstal","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"2024071216422907600_dgae088-B13","doi-asserted-by":"crossref","first-page":"109858","DOI":"10.1016\/j.diabres.2022.109858","article-title":"Patch pumps: what are the advantages for people with diabetes?","volume":"187","author":"Kulzer","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"2024071216422907600_dgae088-B14","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1089\/dia.2016.0239","article-title":"Impact of the omnipod(\u00ae) insulin management system on quality of life: a survey of current users","volume":"18","author":"Polonsky","year":"2016","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"2024071216422907600_dgae088-B15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11892-022-01468-x","article-title":"Friend or foe: a narrative review of the impact of diabetes technology on sleep","volume":"22","author":"Cobry","year":"2022","journal-title":"Current Diab Rep"},{"issue":"1","key":"2024071216422907600_dgae088-B16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-022-05744-z","article-title":"Automated insulin delivery: benefits, challenges, and recommendations. A consensus report of the joint diabetes technology working group of the European association for the study of diabetes and the American diabetes association","volume":"66","author":"Sherr","year":"2023","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"2024071216422907600_dgae088-B17","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.2337\/dc21-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021","volume":"44","author":"American Diabetes Association","year":"2021","journal-title":"Diabetes Care"},{"issue":"1","key":"2024071216422907600_dgae088-B18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s40814-023-01400-4","article-title":"A pilot randomised controlled parallel arm trial evaluating treatment satisfaction with the Omnipod DASH\u00ae insulin management system compared with usual care in adults with type 1 diabetes in Australia: rationale, study design and methodologies","volume":"9","author":"Kong","year":"2023","journal-title":"Pilot Feasibility Stud"},{"issue":"11","key":"2024071216422907600_dgae088-B19","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1089\/dia.2014.0378","article-title":"The performance and usability of a factory-calibrated flash glucose monitoring system","volume":"17","author":"Bailey","year":"2015","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"2024071216422907600_dgae088-B20","doi-asserted-by":"crossref","first-page":"e000025","DOI":"10.1136\/bmjdrc-2014-000025","article-title":"Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents","volume":"2","author":"Barnard","year":"2014","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"9","key":"2024071216422907600_dgae088-B21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1089\/dia.2010.0015","article-title":"Validation of measures of satisfaction with and impact of continuous and conventional glucose monitoring","volume":"12","author":"JDRF Continuous Glucose Monitoring Study Group","year":"2010","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"2024071216422907600_dgae088-B22","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1177\/1932296817702656","article-title":"Closing the loop in adults, children and adolescents with suboptimally controlled type 1 diabetes under free living conditions: a psychosocial substudy","volume":"11","author":"Barnard","year":"2017","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"2024071216422907600_dgae088-B23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2337\/dc20-1060","article-title":"A randomized clinical trial assessing continuous glucose monitoring (CGM) use with standardized education with or without a family behavioral intervention compared with fingerstick blood glucose monitoring in very young children with type 1 diabetes","volume":"44","author":"Strategies to Enhance New CGM Use in Early Childhood (SENCE) Study Group","year":"2021","journal-title":"Diabetes Care"},{"issue":"1","key":"2024071216422907600_dgae088-B24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00592-021-01789-5","article-title":"Improved technology satisfaction and sleep quality with medtronic MiniMed\u00ae advanced hybrid closed-loop delivery compared to predictive low glucose suspend in people with type 1 diabetes in a randomized crossover trial","volume":"59","author":"Wheeler","year":"2022","journal-title":"Acta Diabetol"},{"issue":"10","key":"2024071216422907600_dgae088-B25","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/dme.12453","article-title":"Development and validation of the diabetes medication system rating questionnaire-short form","volume":"31","author":"Peyrot","year":"2014","journal-title":"Diabet Med"},{"issue":"1","key":"2024071216422907600_dgae088-B26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/1541931213571043","article-title":"Validation of the system usability scale (SUS):SUS in the wild","volume":"57","author":"Peres","year":"2013","journal-title":"Proc Hum Factors Ergon Soc Annu Meet"},{"issue":"4","key":"2024071216422907600_dgae088-B27","first-page":"40","article-title":"Construction of a benchmark for the user experience questionnaire (UEQ)","volume":"4","author":"Schrepp","year":"2017","journal-title":"Int J Interact Multimed Artif Intell"},{"issue":"8","key":"2024071216422907600_dgae088-B28","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"issue":"6","key":"2024071216422907600_dgae088-B29","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1177\/19322968211035110","article-title":"First randomized controlled trial of hybrid closed loop versus multiple daily injections or insulin pump using self-monitoring of blood glucose in free-living adults with type 1 diabetes undertaking exercise","volume":"15","author":"Paldus","year":"2021","journal-title":"J Diabetes Sci Technol"},{"issue":"Suppl. 1","key":"2024071216422907600_dgae088-B30","doi-asserted-by":"crossref","first-page":"922-P","DOI":"10.2337\/db23-922-P","article-title":"922-P: improved satisfaction while maintaining safety and high time in range (TIR) with a medtronic investigational enhanced advanced hybrid closed-loop system (eAHCL)","volume":"72","author":"Yuan","year":"2023","journal-title":"Diabetes"},{"issue":"5","key":"2024071216422907600_dgae088-B31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/dia.2011.0228","article-title":"Patient perceptions of using the OmniPod system compared with conventional insulin pumps in young adults with type 1 diabetes","volume":"14","author":"Lebenthal","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"2024071216422907600_dgae088-B32","doi-asserted-by":"crossref","first-page":"108735","DOI":"10.1016\/j.diabres.2021.108735","article-title":"Improved glycemic control in 3,592 adults with type 2 diabetes mellitus initiating a tubeless insulin management system","volume":"174","author":"Carlson","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"2024071216422907600_dgae088-B33","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1177\/1932296819868698","article-title":"Glycemic control and factors impacting treatment choice in tubeless insulin pump users: a survey of the T1D exchange glu online community","volume":"13","author":"Layne","year":"2019","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"2024071216422907600_dgae088-B34","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1177\/1932296816638674","article-title":"Efficacy of the omnipod insulin management system on glycemic control in patients with type 1 diabetes previously treated with multiple daily injections or continuous subcutaneous insulin infusion","volume":"10","author":"Layne","year":"2016","journal-title":"J Diabetes Sci Technol"},{"issue":"9","key":"2024071216422907600_dgae088-B35","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.2337\/dc06-0986","article-title":"OmniPod insulin management system: patient perceptions, preference, and glycemic control","volume":"29","author":"Zisser","year":"2006","journal-title":"Diabetes Care"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae088\/56769057\/dgae088.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/8\/1984\/58530469\/dgae088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/8\/1984\/58530469\/dgae088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T16:44:29Z","timestamp":1720802669000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/8\/1984\/7610799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,19]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,2,19]]},"published-print":{"date-parts":[[2024,7,12]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae088","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,2,19]]}}}